Danaher (DHR) Net Income towards Common Stockholders (2009 - 2026)
Danaher (DHR) posted quarterly Net Income towards Common Stockholders of $870.0 million for Q2 2026, up 56.76% year-over-year from $555.0 million in Q2 2025, and down 15.45% quarter-over-quarter from $1.0 billion in Q1 2026.
Danaher (DHR) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Danaher's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $870.0 million for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 56.76% year-over-year to $870.0 million; the TTM figure through Jun 2026 stood at $4.0 billion (up 16.91% YoY), while the FY2025 annual figure was $3.6 billion, down 7.31% from the prior year.
- Net Income towards Common Stockholders for Q2 2026 stood at $870.0 million, down from $1.0 billion in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $2.2 billion in Q4 2022, with the low at $555.0 million in Q2 2025.
- The 5-year median for Net Income towards Common Stockholders is $1.1 billion (2024), against an average of $1.2 billion.
- The sharpest annual moves came in 2023 and 2026: Net Income towards Common Stockholders slumped 51.18% in 2023, then jumped 56.76% in 2026.
- Danaher's Net Income towards Common Stockholders stood at $2.2 billion in 2022, then plunged by 51.18% to $1.1 billion in 2023, then rose by 0.65% to $1.1 billion in 2024, then rose by 8.93% to $1.2 billion in 2025, then slipped by 26.46% to $870.0 million in 2026.
- Business Quant data shows DHR's Net Income towards Common Stockholders at $870.0 million in Q2 2026, $1.0 billion in Q1 2026, and $1.2 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 324.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 870.00 Mn |
| Mar 27, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.18 Bn |
| Sep 26, 2025 | 908.00 Mn |
| Jun 27, 2025 | 555.00 Mn |
| Mar 28, 2025 | 954.00 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 27, 2024 | 818.00 Mn |
| Jun 28, 2024 | 907.00 Mn |
| Mar 29, 2024 | 1.09 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 29, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.11 Bn |
| Mar 31, 2023 | 1.43 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jul 1, 2022 | 1.66 Bn |
| Apr 1, 2022 | 1.68 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Oct 1, 2021 | 1.12 Bn |